GLP-1 Dose Titration Guide: Your 0.25mg to 2.4mg Journey

GLP-1 Dose Titration Guide: Your 0.25mg to 2.4mg Journey

Starting semaglutide is one of the most important steps a GLP-1 user takes. Understanding why your dose changes over weeks and months — and what to expect at every stage — is equally important. Many patients in India abandon their medication during the titration phase because of side effects they were not prepared for, or because they rushed to higher doses too quickly.

This guide explains the entire titration process clearly, covering all major GLP-1 medications available in India in 2026: Ozempic, Wegovy, Rybelsus, and popular Indian generics like Semafit, Semaglut, and Zuglim.

Consult your healthcare provider before starting any medication. Never change your dose without medical guidance.

What Is Titration and Why Does It Exist?

Titration means gradually increasing your dose over weeks or months. GLP-1 receptor agonists are never started at their full therapeutic dose because the side effects — nausea, vomiting, bloating, diarrhea — would be overwhelming at higher doses without prior adaptation.

The logic is straightforward: your GLP-1 receptors in the gut, brain, and pancreas need time to adapt to the medication. A slow, steady increase allows your body to build tolerance to the GI side effects while progressively receiving more of the metabolic benefits.

Rushing titration is the single most common reason patients give up on GLP-1 therapy in India.

Standard Titration Schedules

Semaglutide Injectable — Weight Management (Wegovy / Indian Generics)

| Week | Dose | What to Expect | |------|------|---------------| | Weeks 1–4 | 0.25mg weekly | Mild appetite reduction, minimal side effects | | Weeks 5–8 | 0.5mg weekly | Noticeable satiety, possible nausea after injection | | Weeks 9–12 | 1.0mg weekly | Significant appetite suppression, food aversions may begin | | Weeks 13–16 | 1.7mg weekly | Strong appetite suppression, most rapid weight loss phase | | Week 17+ | 2.4mg weekly | Full therapeutic dose; side effects usually stabilise |

Semaglutide Injectable — Type 2 Diabetes (Ozempic)

| Week | Dose | Notes | |------|------|-------| | Weeks 1–4 | 0.25mg weekly | Initiation dose — not therapeutic | | Weeks 5+ | 0.5mg weekly | Initial therapeutic dose | | After 4+ weeks at 0.5mg | 1.0mg weekly | If HbA1c target not met | | Maximum | 2.0mg weekly | For patients needing greater glycaemic control |

Rybelsus (Oral Semaglutide)

| Month | Dose | Key Rule | |-------|------|----------| | Month 1 | 3mg daily | Must take 30 min before any food/drink with 120ml water only | | Month 2 | 7mg daily | Same fasting rule applies | | Month 3+ | 14mg daily | Maintenance dose |

Note: Oral semaglutide has lower bioavailability (~1%) compared to injectable. This is why the mg doses appear much higher for equivalent effect.

What to Expect at Each Stage

Stage 1: 0.25mg (Weeks 1–4) — The Quiet Beginning

Most patients are surprised by how little they feel at this dose. Appetite may be slightly reduced. Some notice mild nausea in the first 1–2 days after injection, which typically resolves by day 3–4. Energy levels are usually unchanged.

Common mistakes at this stage: Increasing the dose early because "nothing is happening." Do not do this. The 0.25mg phase is about building tolerance, not losing weight.

Stage 2: 0.5mg (Weeks 5–8) — The First Real Change

This is when most patients first notice meaningful appetite suppression. Portions naturally decrease. The scale starts moving. Nausea is most common at this stage, particularly after eating fatty or very sweet foods. Many patients in India report nausea lasting 4–6 hours after eating heavy meals like biryani, heavy curries, or restaurant food.

Practical tip: Keep meals light and protein-focused on injection day and the day after. Avoid large social meals on these days.

Stage 3: 1.0mg (Weeks 9–12) — Substantial Change

For diabetic patients using Ozempic, 1.0mg is often the long-term maintenance dose. For weight loss patients, this is the halfway point. Food aversions frequently begin here — foods that were previously enjoyable (often very sweet, very greasy, or very heavy items) may become unappealing. This is a normal pharmacological effect, not a psychological problem.

Hair thinning may begin to emerge around this stage in some patients — this is related to rapid weight loss and caloric restriction, not the medication itself. Increasing protein intake proactively helps significantly.

Stage 4: 1.7mg (Weeks 13–16) — Strong Suppression

Appetite suppression is intense at this stage. Many patients report eating only 2 small meals per day and feeling completely satisfied. This is the phase where muscle loss risk is highest — ensure protein intake is at least 1.2g per kg body weight daily.

Social eating becomes challenging. Restaurant portions feel overwhelming. Many Indian patients find family meals or celebration events difficult at this stage. Communicate with family members about your reduced appetite — it is a medication effect, not a lifestyle choice.

Stage 5: 2.4mg (Week 17+) — Full Therapeutic Dose

The full therapeutic dose. The STEP 1 trial showed the greatest weight loss benefit at 2.4mg (14.9% average weight reduction). Paradoxically, many patients find side effects are less severe at this stage compared to the 1.0–1.7mg phases — the body has adapted.

Most patients stay at this dose indefinitely, or until they and their doctor decide to taper or discontinue.

Can I Slow Down My Titration?

Yes — and in India, this is often the right choice. Many doctors at AIIMS, Apollo, Fortis, and independent obesity clinics now recommend an extended titration protocol for patients who are highly sensitive to GI side effects:

• Spend 6–8 weeks at each dose level instead of 4
• If nausea is severe (vomiting more than once per day), stay at the current dose for an additional 4 weeks before increasing
• There is no evidence that faster titration improves long-term outcomes

Always discuss your titration pace with your prescribing doctor. A slower journey is better than abandoning treatment.

Missed Dose — What to Do

• Missed within 5 days of scheduled injection: Take the missed dose as soon as you remember. Resume your regular weekly schedule from there.
• Missed more than 5 days ago: Skip the missed dose entirely. Take the next dose on your regular scheduled day.
• Never double-dose. Taking two doses close together significantly increases nausea and vomiting risk.

Indian Brand Notes (2026)

Several Indian generic semaglutide brands are now widely prescribed. The doses are bioequivalent to branded Ozempic/Wegovy, but pen mechanisms differ:

| Brand | Approx. Monthly Cost | Pen Type | |-------|---------------------|----------| | Semafit (Sun Pharma) | ₹3,500–5,000 | Pre-filled pen | | Semaglut (Cipla) | ₹3,200–4,500 | Pre-filled pen | | Ozempic (Novo Nordisk) | ₹12,000–16,000 | FlexPen | | Wegovy (imported) | ₹35,000–50,000 | FlexTouch Pen |

Always read your specific brand's pen instructions — injection technique varies between devices.

Common Mistakes to Avoid

1. Rushing titration to match a friend's dose or online comparisons
2. Stopping medication at the first sign of nausea rather than managing it
3. Eating large, heavy meals on injection day — guaranteed nausea
4. Taking the Rybelsus pill with food — must be taken 30 minutes before on an empty stomach with water only
5. Increasing to 2.4mg without first spending adequate time at 1.7mg

When to Consult Your Doctor

See your doctor before:

• Increasing beyond 1.0mg
• Combining GLP-1 with other diabetes medications (risk of hypoglycaemia)
• Any planned surgery (GLP-1 may need to be paused 7–14 days before anaesthesia)
• Planning pregnancy or if pregnancy is suspected
• Experiencing persistent vomiting, severe abdominal pain, or signs of dehydration

FAQ

Q: My colleague started at 0.5mg and jumped to 2.4mg in 2 months. Is that safe? Titration schedules exist for a reason. Self-escalating doses is associated with significantly higher rates of treatment discontinuation due to side effects. Clinical guidelines recommend the schedule above.

Q: I've been at 0.5mg for 3 months and the weight loss has stalled. Should I increase? Discuss with your doctor. Some patients are partial responders at lower doses and respond better at 1.0mg+. However, also review dietary patterns — a dietary plateau (eating more calories than expected) is a more common reason for stalled loss.

Q: Does the 0.25mg dose actually do anything? It is not designed to produce significant weight loss — it is a tolerance-building dose. Some patients notice mild appetite reduction, but the primary purpose is to minimise GI side effects when the dose increases.

Q: Can I stay at 1.0mg permanently? Yes, many diabetic patients and some weight loss patients maintain excellent results at 1.0mg indefinitely. Discuss your long-term target with your doctor.